loading page

Actual use of PROMs in Asthma and Rhinitis recommended by guidelines in clinical settings: PROMUSE Respiratory Study
  • +25
  • Ivan Cherrez-Ojeda,
  • Jean Bousquet,
  • Torsten Zuberbier,
  • Juan Calderón,
  • Pavel Kolkhir,
  • Anastasiia Allenova,
  • Audrey Allenov,
  • Sergey Tkachenko,
  • Florin Mihaltan,
  • Ruxandra Ulmeanu,
  • Mona Al-Ahmad ,
  • Monica Rodriguez Gonzalez,
  • Guillermo Hideo Wakida-Kuzunoki,
  • German Ramón,
  • Maia Rukhadze,
  • Désirée Larenas-Linnemann,
  • Mitja Kosnik,
  • Juan Carlos Ivancevich,
  • Luis Ensina,
  • Nelson Rosario,
  • Violeta Kvedariene,
  • Herberto Chong Neto,
  • Ivan Tinoco,
  • Anna Bedbrook,
  • Marco Faytong-Haro,
  • Marcus Maurer,
  • Oliver Pfaar,
  • Karla Robles-Velasco
Ivan Cherrez-Ojeda
Charité-Universitätsmedizin Berlin

Corresponding Author:ivan.cherrez-ojeda@charite.de

Author Profile
Jean Bousquet
Charité-Universitätsmedizin Berlin
Author Profile
Torsten Zuberbier
Charité-Universitätsmedizin Berlin
Author Profile
Juan Calderón
Universidad Espiritu Santo
Author Profile
Pavel Kolkhir
Charité-Universitätsmedizin Berlin
Author Profile
Anastasiia Allenova
Biomedical Science and Technology Park First Moscow State Medical University named after IM Sechenov (Sechenov University
Author Profile
Audrey Allenov
IM Sechenov First Moscow State Medical University (Sechenov University
Author Profile
Sergey Tkachenko
Russian Medical Academy of Сontinuous Professional Education of the Ministry of Health of the Russian Federation
Author Profile
Florin Mihaltan
National Institute of Pneumology M Nasta
Author Profile
Ruxandra Ulmeanu
National Institute of Pneumology M Nasta
Author Profile
Mona Al-Ahmad
University of Kuwait
Author Profile
Monica Rodriguez Gonzalez
Hospital Español de México
Author Profile
Guillermo Hideo Wakida-Kuzunoki
Colegio Mexicano de Pediatras Especialistas en Inmunología Clínica y Alergia
Author Profile
German Ramón
Hospital Italiano Regional del Sur
Author Profile
Maia Rukhadze
Center Allergy&Immunology
Author Profile
Désirée Larenas-Linnemann
Center of Excellence in Asthma and Allergy Médica Sur Clinical Foundation and Hospital
Author Profile
Mitja Kosnik
University Clinic Golnik
Author Profile
Juan Carlos Ivancevich
Servicio de Alergia e Immunologia Clinica Santa Isabel Buenos Aires
Author Profile
Luis Ensina
Federal University of São Paulo
Author Profile
Nelson Rosario
Federal University of Parana
Author Profile
Violeta Kvedariene
Vilnius University and Institute of Clinical Medicine Clinic of Chest diseases Immunology and Allergology Faculty of Medicine
Author Profile
Herberto Chong Neto
Hospital de Clínicas Federal University of Paraná (UFPR
Author Profile
Ivan Tinoco
Centro de Alergia Tinoco
Author Profile
Anna Bedbrook
MASK-air SAS
Author Profile
Marco Faytong-Haro
Universidad Estatal de Milagro
Author Profile
Marcus Maurer
Charité-Universitätsmedizin Berlin
Author Profile
Oliver Pfaar
University Hospital Marburg
Author Profile
Karla Robles-Velasco
Universidad Espiritu Santo
Author Profile

Abstract

Background: Guidelines advise for the implementation of patient-reported outcomes (PROMs). Our objective is to identify the utilization patterns of PROMs, together with the reasons for their usage and the barriers to their adoption among practitioners managing patients with asthma, allergic rhinitis (AR), and rhinosinusitis (RS). Methods: This was a cross-sectional observational study using a questionnaire encompassing all pertinent PROMs and disseminated to practitioners associated with the ARIA, UCARE, ADCARE, and ACARE networks. Individuals unfamiliar with PROMS or lacking prior experience with it were eliminated. Descriptive and analytical data were utilized, categorized by the frequency and type of PROMs applied. Stata 18.0 was utilized, with p<0.05 indicating statistical significance. Results: A total of 439 practitioners participated, with PROMs predominantly utilized by physicians certified for over 30 years and by respiratory specialists (16.67% and 12.46%, respectively; p<0.05). Pulmonologists exhibited the greatest utilization of asthma PROMs at 86%, while allergists predominantly employed AR and RS PROMs at 38.42% and 33.33%, respectively (p < 0.001). ACT (66.74%), RCAT (27.79%), and SNOTT22 (15.26%) were the predominant PROMs utilized primarily for asthma (79.19%), AR (51.23%), and RS (57.26%), respectively (p<0.001). The foremost purposes for their application were disease control monitoring (93.39%) and evaluation of performance of therapy approaches (90.2%). The most significant barrier identified was time constraint, rated at 75.40% (p>0.05 across all groups). Conclusions: The use of PROMs is suboptimal, primarily due to time limitations. It is imperative that methods be swiftly implemented to include these techniques into the therapeutic environment to attain enhanced outcomes.
16 Jan 2025Submitted to Allergy
17 Jan 2025Submission Checks Completed
17 Jan 2025Assigned to Editor
17 Jan 2025Review(s) Completed, Editorial Evaluation Pending
18 Jan 2025Reviewer(s) Assigned